Veradermics (MANE) Accounts Payables (2024 - 2026)

Veradermics' Accounts Payables history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• Quarterly Accounts Payables changed N/A year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (changed N/A YoY) and the FY2025 annual result came in at $2.1 million, down 5.43% from the prior year.
• Accounts Payables was $1.1 million for Q1 2026 at Veradermics, down from $2.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $2.2 million in Q4 2024 and bottomed at $1.1 million in Q1 2026.
• A 3-year average of $1.8 million and a median of $2.1 million in 2025 frame the typical range for Accounts Payables.
• Peak annual rise in Accounts Payables reached 5.43% in 2025, while the deepest fall reached 5.43% in 2025.
• Veradermics' Accounts Payables stood at $2.2 million in 2024, then fell by 5.43% to $2.1 million in 2025, then tumbled by 49.62% to $1.1 million in 2026.
• Business Quant data shows MANE's Accounts Payables at $1.1 million in Q1 2026, $2.1 million in Q4 2025, and $2.2 million in Q4 2024.